Expression and diagnostic value of miR-34c and miR-141 in serum of patients with colon cancer

por Wu, Huijing, Yan, Hongxia
Publicado 2020

Value of CT spectral imaging in the differential diagnosis of sarcoidosis and Hodgkin’s lymphoma based on mediastinal enlarged lymph node: A STARD compliant article

por Cao, Lixiu, Wu, Huijing, Liu, Yongliang
Publicado 2022

Polyploid Induction and Identification of Rosa roxburghii f. eseiosa

por Wu, Huijing, Jiang, Lanlan, Li, Jin’e, Lu, Min, An, Huaming
Publicado 2023

Effect of erlotinib combined with cisplatin on IL-6 and IL-12 in mice with Lewis lung cancer

por Zhang, Xu, Chen, Jinliang, Jin, Hongsong, Zhao, Wei, Chang, Zhibo, Wu, Huijing
Publicado 2020

Lung cancer with brain metastases remaining in continuous complete remission due to pembrolizumab and temozolomide: a case report

por Zhu, Xianmin, Dong, Shuang, Tang, Jing, Xie, Rong, Wu, Huijing, Hofman, Paul, Mrugala, Maciej M., Hu, Sheng
Publicado 2022

PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer

por Zhang, Jing, Zhu, Zhonglin, Wu, Huijing, Yu, Zhilong, Rong, Zeyin, Luo, Zai, Xu, Yiwei, Huang, Kejian, Qiu, Zhengjun, Huang, Chen
Publicado 2018

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside

por Shao, Liang, Xu, Chengshi, Wu, Huijing, Jamal, Muhammad, Pan, Shan, Li, Sirui, Chen, Fei, Yu, Ding, Liu, Kui, Wei, Yongchang
Publicado 2021

Utilization of dental services and associated factors among preschool children in China

por Gao, Xiaoli, Ding, Min, Xu, Mengru, Wu, Huijing, Zhang, Chunzi, Wang, Xing, Feng, Xiping, Tai, Baojun, Hu, Deyu, Lin, Huancai, Wang, Bo, Zheng, Shuguo, Liu, Xuenan, Rong, Wensheng, Wang, Weijian, Wang, Chunxiao, Si, Yan
Publicado 2020

Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T‐cell lymphoma in China

por Wei, Chong, Li, Wei, Qin, Liping, Liu, Shan, Xue, Chang, Ren, Kexing, Zhang, Zirong, Liu, Caili, Bao, Fang, Zhang, Huilai, Zhou, Hui, Li, Zhiming, Wu, Huijing, Zou, Liqun, Liu, Lihong, Jing, Hongmei, Zhang, Wei
Publicado 2022

PB2272: PI3KΔ INHIBITOR LINPERLISIB FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL

por Qiu, Lihua, Wang, Tingyu, Sun, Xiuhua, Su, Hang, Cao, Junning, LI, Zhi-Ming, Song, Yuqin, Zhang, LI, LI, Dengju, Wu, Huijing, Zhang, Wei, LI, Junmin, Zhou, Keshu, Zhou, Hui, Yang, Yu, LI, Zhifeng, Cen, Hong, Cai, Zhen, Zhang, Zhihui, Fu, Weijun, Jin, Jie, LI, Fei, Wu, Weixin, Gu, Xuekui, Zhu, Weiliang, Liu, Lihong, LI, Zengjun, Yi, Shuhua, Qiu, Lugui
Publicado 2023

PB2269: PI3KΔ INHIBITOR LINPERLISIB FOR ELDERLY PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL

por Sun, Xiuhua, Wang, Tingyu, Qiu, Lihua, Su, Hang, Cao, Junning, LI, Zhi-Ming, Song, Yuqin, Zhang, LI, LI, Dengju, Wu, Huijing, Zhang, Wei, LI, Junmin, Zhou, Keshu, Zhou, Hui, Yang, Yu, LI, Zhifeng, Cen, Hong, Cai, Zhen, Zhang, Zhihui, Fu, Weijun, Jin, Jie, LI, Fei, Wu, Weixin, Gu, Xuekui, Zhu, Weiliang, Liu, Lihong, LI, Zengjun, Yi, Shuhua, Qiu, Lugui
Publicado 2023

The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

por Wang, Tingyu, Sun, Xiuhua, Qiu, Lihua, Su, Hang, Cao, Junning, Li, Zhiming, Song, Yuqin, Zhang, Li, Li, Dengju, Wu, Huijing, Zhang, Wei, Li, Junmin, Zhou, Keshu, Zhou, Hui, Yang, Yu, Li, Zhifeng, Cen, Hong, Cai, Zhen, Zhang, Zhihui, Fu, Weijun, Jin, Jie, Li, Fei, Wu, Weixin, Gu, Xuekui, Zhu, Weiliang, Liu, Lihong, Li, Zengjun, Yi, Shuhua, Bao, Hanying, Xu, Zusheng, Qiu, Lugui
Publicado 2023